If you meant to tase me then I implore your weapon to transmit jolts of infinite mercy that invites tranquility.
And
If you meant to shoot me then I implore your weapon to discharge bullets that provide validation to a dehisced vexed wound.
And
If you meant to place your genu on my listless collum then I implore your weapon to release oxygenated synovial fluid that coats my cyanotic vasculature.
And
If you meant to pepper spray me then I implore your weapon to deliver capsaicin that has paradoxical effects on my traumatized orbits.
And
If you meant for me to silence my first amendment larynx then I implore your weapon of invalidation to be disarmed by the divine whose spirit weeps unapologetically.
And
If you meant to justify the carnage of my fellow Black brothers and sisters with explicit bias then I implore your weapon of septic optic nerves to be repaired with the balm of shared humanity.
Dr Clark is clinical assistant professor at the University of South Carolina School of Medicine-Greenville and medical director & division chief for Adult Inpatient and Consult-Liaison Services for the Department of Psychiatry and Behavioral Medicine at Prisma Health-Upstate. He currently serves on the APA Task Force to Address Structural Racism Throughout Psychiatry as well as the Diversity & Inclusion Section Editor and Advisory Board member for Psychiatric TimesTM.
Lisa Harding, MD, urges psychiatrists to gather histories, deprescribe safely, and send focused sleep referrals now that orexin agonists have arrived for narcolepsy.
Once-monthly subcutaneous olanzapine TEV-749 shows sustained stabilization and remission in schizophrenia, supports direct switching, and avoids post-injection monitoring.
Real-world data links once-monthly Uzedy to fewer ER visits, better adherence, and lower costs—plus fewer bipolar I relapses when switching from pills.
Veterans younger than 30 starting antidepressants, and anyone coprescribed opioids and benzodiazepines, will need to sign consent forms starting in 2027.
Policy shifts have opened the door to telehealth buprenorphine for pregnant and postpartum women with OUD, but research, guidelines, and state policy lag behind.